The problem
A replacement artery narrower than 6 mm must stay open as it integrates with the recipient’s tissue. Which ready-made graft can do this durably in people? Reinforced biotubes, made from tissue grown around a mesh and then stripped of cells, supported flow in separate 2026 animal models: 12-month canine carotid replacement and 3-month pig coronary bypass. The 6-mm dialysis-access model tested a different use.[1] [2]
Scope
Off-the-shelf tissue-engineered grafts below 6 mm for arterial reconstruction, combining durable patency, mechanical compatibility and safe host remodelling in human use.
What remains open
Clinical translation must preserve patency by addressing thrombosis and narrowing, as well as compliance mismatch—unequal expansion of graft and artery under pressure—and long-term remodelling as scaffold materials degrade. The below-6-mm arterial target is distinct from larger grafts and repeated-puncture dialysis access.[1] [2]
Why it matters
A ready-made graft could help when suitable natural vessels are unavailable.[1]
Definitions
2 terms
patency
A graft’s remaining open so that blood can pass through it. Patency is measured over a stated follow-up period and does not alone establish every aspect of safety.[1] [2]
compliance mismatch
A difference in how much a graft and the adjoining artery expand under changing blood pressure. This mechanical mismatch can contribute to narrowing at their connection.[2]
Sources
- Reinforced biotubes as readily available and regenerative vascular grafts
Notes on Reinforced biotubes as readily available and regenerative vascular grafts
Large-animal arterial and dialysis-access tests have different graft sizes and follow-up periods.
- Barriers to clinical translation of small-diameter tissue-engineered vascular grafts in peripheral reconstruction
Notes on Barriers to clinical translation of small-diameter tissue-engineered vascular grafts in peripheral reconstruction
Researcher review identifies graft failure mechanisms and remaining clinical validation needs.